Drug intelligence / Profile preview

sulforaphane

Development stage
Phase 4
Lead developer
TheraCryf
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Sulforaphane is a naturally occurring isothiocyanate compound found in cruciferous vegetables such as broccoli, Brussels sprouts, and cabbage. It is produced when the enzyme myrosinase converts glucoraphanin (a glucosinolate precursor) into sulforaphane upon plant tissue damage (e.g., chewing or chopping)[3][1][6]. Sulforaphane exists as two stereoisomers; the R-enantiomer occurs naturally, while the S-enantiomer can be synthesized[3][1]. It acts primarily as an inducer of phase II detoxification enzymes via activation of the NRF2 signaling pathway and displays antioxidant, anticarcinogenic, antidiabetic, and antimicrobial properties in experimental models[8][6][7]. Despite promising preclinical data on cancer prevention and other health benefits, there is no conclusive clinical evidence supporting its efficacy for disease prevention or treatment as of 2025[3].

Other names
萝卜硫素sulphoraphanesulforafan1-isothiocyanato-4-methylsulfinylbutane4-methylsulfinylbutyl isothiocyanateSulforaphan
02

Targets

KEAP1 (Kelch-like ECH-associated protein 1)

Beyond the preview

Go deeper on sulforaphane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sulforaphane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call